Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases

Simone Saibeni, Maria J. Etchevers, Dolors Tassies, Julián Panés, Joan C. Reverter, Silvio Danese, Josep M. Piqué, Savino Bruno, Maurizio Vecchi, Maurizio Vecchiarelli, Antonio Gasbarrini, Miquel Sans

Research output: Contribution to journalArticle

Abstract

In inflammatory bowel diseases (IBD), risk of thrombosis and production of antibodies are increased. In autoimmune and inflammatory disorders, a role of anti-prothrombin (aPT) antibodies in developing thrombosis has been hypothesised. The aim of the study is to evaluate the prevalence of aPT antibodies in IBD patients, with and without thrombosis.
Original languageEnglish
Pages (from-to)1281-1286
Number of pages6
JournalInternational Journal of Colorectal Disease
Volume28
DOIs
Publication statusPublished - 2013

Keywords

  • Thrombosis

Fingerprint

Dive into the research topics of 'Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases'. Together they form a unique fingerprint.

Cite this